The effects of coronary artery disease severity on time-dependent changes in platelet activation indices in stored

Christopher J Boos1, Balu Balakrishnan, Gregory Y H Lip

  • 1Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, B18 7QH, UK.

Insights

Platelet activation indices like MPV, MPC, and PCDW change over time when stored in EDTA tubes. These temporal changes in platelet markers are not affected by cardiovascular disease severity.

Area of Science:

  • Hematology
  • Cardiovascular Disease Research
  • Biomarker Analysis

Background:

  • Platelets are crucial in cardiovascular disease (CVD) pathogenesis.
  • Platelet activation indices are emerging as CVD risk stratification markers.
  • The impact of disease severity on temporal changes in these indices remains understudied.

Purpose of the Study:

  • To investigate the effects of whole blood storage time on platelet activation indices.
  • To determine if underlying cardiovascular disease severity influences these time-dependent changes.

Main Methods:

  • Assessed mean platelet volume (MPV), mean platelet component (MPC), and platelet component distribution width (PCDW) using an ADVIA 120 analyser.
  • Studied healthy controls, stable coronary artery disease (CAD) patients, and acute myocardial infarction (AMI) patients.
  • Monitored changes in platelet indices over 120 minutes of whole blood storage at room temperature in EDTA tubes.

Main Results:

  • MPV significantly increased and PCDW significantly decreased over storage time (P < 0.05).
  • MPC showed a significant time-dependent decrease (P < 0.05).
  • No significant interaction was found between underlying disease severity and time-dependent changes for any platelet index.

Conclusions:

  • Temporal changes in MPV, MPC, and PCDW occur within 2 hours of whole blood storage in EDTA.
  • These storage-related alterations in platelet indices are independent of cardiovascular disease severity.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...